Paul Christopher Williams - 20 May 2024 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Valerie Barnett, Attorney-in-Fact
Issuer symbol
CTKB
Transactions as of
20 May 2024
Net transactions value
-$17,445
Form type
4
Filing time
22 May 2024, 18:34:40 UTC
Previous filing
13 Mar 2024
Next filing
21 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Options Exercise +1,006 +19% 6,323 20 May 2024 Direct F1
transaction CTKB Common Stock Tax liability $2,336 -392 -6.2% $5.96 5,931 20 May 2024 Direct F2
transaction CTKB Common Stock Options Exercise +613 +10% 6,544 20 May 2024 Direct F1
transaction CTKB Common Stock Tax liability $1,424 -239 -3.7% $5.96 6,305 20 May 2024 Direct
transaction CTKB Common Stock Options Exercise +5,893 +93% 12,198 20 May 2024 Direct F1
transaction CTKB Common Stock Tax liability $13,684 -2,296 -19% $5.96 9,902 20 May 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Restricted Stock Units Options Exercise $0 -1,006 -9.1% $0.000000 10,069 20 May 2024 Common Stock 1,006 Direct F1, F3
transaction CTKB Restricted Stock Units Options Exercise $0 -613 -5.5% $0.000000 10,433 20 May 2024 Common Stock 613 Direct F1, F4
transaction CTKB Restricted Stock Units Options Exercise $0 -5,893 -4.2% $0.000000 135,549 20 May 2024 Common Stock 5,893 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
F2 Represents the number of shares withheld by and surrendered to the Issuer on May 20, 2024, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
F3 The shares subject to the RSU Award shall vest over 4 years with 12/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and 3/48 of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on February 18, May 18, August 18 and November 18.
F4 The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.
F5 The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2024 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2025 and each March 10 thereafter.